These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18459215)

  • 1. India: Court upholds patent law denying patents for slightly modified versions of existing drugs.
    Swamy M
    HIV AIDS Policy Law Rev; 2007 Dec; 12(2-3):50-1. PubMed ID: 18459215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to medicine and the dangers of patent linkage: lessons from Bayer Corp v. Union of India.
    Tsui M
    J Law Med; 2011 Mar; 18(3):577-88. PubMed ID: 21528741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taking TRIPS to India--Novartis, patent law, and access to medicines.
    Mueller JM
    N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
    [No Abstract]   [Full Text] [Related]  

  • 4. "To patent or not to patent? the case of Novartis' cancer drug Glivec in India".
    Gabble R; Kohler JC
    Global Health; 2014 Jan; 10():3. PubMed ID: 24393270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Glivec® case: the first example of a global debate on the drug patent system].
    Moital I; Bosch F; Farré M; Maddaleno M; Baños JE
    Gac Sanit; 2014; 28(6):470-4. PubMed ID: 25110309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patent dispute: Delhi High Court gives a boost to access to affordable medicines.
    Menghaney L
    Indian J Med Ethics; 2010; 7(2):97-100. PubMed ID: 20432882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supreme Court rules against drug patent "evergreening".
    Kondro W
    CMAJ; 2006 Dec; 175(12):1508-9. PubMed ID: 17146081
    [No Abstract]   [Full Text] [Related]  

  • 8. A victory for global public health in the Indian Supreme Court.
    't Hoen E
    J Public Health Policy; 2013 Aug; 34(3):370-4. PubMed ID: 23677206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do public health safeguards in Indian patent law affect pharmaceutical patenting in practice?
    Sampat BN; Amin T
    J Health Polit Policy Law; 2013 Aug; 38(4):735-55. PubMed ID: 23645877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novartis challenges India's drug patent laws in Supreme Court.
    Billingsley M
    BMJ; 2012 Feb; 344():e1279. PubMed ID: 22354594
    [No Abstract]   [Full Text] [Related]  

  • 11. Court dismisses Novartis challenge to Indian patent law.
    Mudur G
    BMJ; 2007 Aug; 335(7614):273. PubMed ID: 17690349
    [No Abstract]   [Full Text] [Related]  

  • 12. The Indian Supreme Court's judgment in the case of Glivec(®) - the uncertain future of pharmaceutical patents in India.
    Thikkavarapu PR
    Pharm Pat Anal; 2014 Mar; 3(2):117-9. PubMed ID: 24588585
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug patents: the evergreening problem.
    Collier R
    CMAJ; 2013 Jun; 185(9):E385-6. PubMed ID: 23630239
    [No Abstract]   [Full Text] [Related]  

  • 14. Indian pharmaceutical patent prosecution: The changing role of Section 3(d).
    Sampat BN; Shadlen KC
    PLoS One; 2018; 13(4):e0194714. PubMed ID: 29608604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. India: New patent law may restrict access to HIV/AIDS treatments.
    Cruess G
    HIV AIDS Policy Law Rev; 2005 Aug; 10(2):28-30. PubMed ID: 16365971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intellectual property. Challenges to India's pharmaceutical patent laws.
    Sampat BN; Shadlen KC; Amin TM
    Science; 2012 Jul; 337(6093):414-5. PubMed ID: 22767892
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of the impact of the Uruguay Round Agreements Act on pharmaceutical patents.
    Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL; Beyer A; Visaria J
    Food Drug Law J; 2009; 64(1):171-81. PubMed ID: 19998745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Patent "Evergreening" Restricting Access to Medicine/Device Combination Products?
    Beall RF; Nickerson JW; Kaplan WA; Attaran A
    PLoS One; 2016; 11(2):e0148939. PubMed ID: 26910128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No change in scope for extension of patent term for pharmaceutical substances under Australian law: an update.
    Lyons M; Stark A
    Pharm Pat Anal; 2017 Nov; 6(6):251-254. PubMed ID: 29022759
    [No Abstract]   [Full Text] [Related]  

  • 20. Herbal drug patenting in India: IP potential.
    Sahoo N; Manchikanti P; Dey SH
    J Ethnopharmacol; 2011 Sep; 137(1):289-97. PubMed ID: 21640810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.